Skip to content

Insider · CIK 0001207107

EBSWORTH DAVID R

Reports to the SEC for 2 companies · LONDON, X0

Transactions

35

Companies

2

Filings

5

CIK

0001207107

Forms 4 and 5

Insider transactions

35 trades
DateCompanyValue
2025-10-07VRNAVerona Pharma plcD Disposition to Issuer—
2025-10-07VRNAVerona Pharma plc · Restricted Share UnitM Exercise/Conversion—
2025-10-07VRNAVerona Pharma plcD Disposition to Issuer—
2025-10-07VRNAVerona Pharma plcM Exercise/Conversion—
2025-10-07VRNAVerona Pharma plcD Disposition to Issuer—
2025-08-01VRNAVerona Pharma plcM Exercise/Conversion—
2025-08-01VRNAVerona Pharma plc · Restricted Stock UnitsM Exercise/Conversion—
2025-08-01VRNAVerona Pharma plcS Sale−$25K
2025-05-01VRNAVerona Pharma plcM Exercise/Conversion+$271K
2025-05-01VRNAVerona Pharma plc · Stock Option (Right to Exercise)M Exercise/Conversion—
2025-04-25VRNAVerona Pharma plc · Restricted Share UnitsA Award—
2025-02-26VRNAVerona Pharma plc · Share Option (Right to Exercise)M Exercise/Conversion—
2025-02-26VRNAVerona Pharma plcM Exercise/Conversion+$49.6K
2025-02-26VRNAVerona Pharma plcM Exercise/Conversion+$101K
2025-02-26VRNAVerona Pharma plcM Exercise/Conversion+$256K
2025-02-26VRNAVerona Pharma plcM Exercise/Conversion+$193K
2025-02-26VRNAVerona Pharma plcG Gift—
2025-02-26VRNAVerona Pharma plc · Share Option (Right to Exercise)M Exercise/Conversion—
2025-02-26VRNAVerona Pharma plc · Share Option (Right to Exercise)M Exercise/Conversion—
2025-02-26VRNAVerona Pharma plc · Share Option (Right to Exercise)M Exercise/Conversion—
2024-11-18VRNAVerona Pharma plcP Purchase+$88.8K
2024-11-06VRNAVerona Pharma plcP Purchase+$189K
2024-08-12VRNAVerona Pharma plcP Purchase+$103K
2024-04-29VRNAVerona Pharma plc · Share Options (Right to Buy)A Award—
2023-11-06VRNAVerona Pharma plcP Purchase+$316K
2023-04-28VRNAVerona Pharma plc · Share Options (Right to Buy)A Award—
2022-04-28VRNAVerona Pharma plc · Share Options (Right to Buy)A Award—
2021-08-09VRNAVerona Pharma plc · Share Options (Right to Buy)A Award—
2021-05-04VRNAVerona Pharma plcS Sale−$9,391.205
2021-02-01VRNAVerona Pharma plcS Sale−$11.8K
2006-05-03CURAGEN CORPCommon Stock (Right to Buy)A Award+$57.8K
2006-05-03CURAGEN CORPCommon Stock (Right to Buy)A Award+$9,625
2004-05-27CURAGEN CORPP Purchase+$50K
2004-05-26CURAGEN CORPStock Option (Right to Buy)A Award+$66.8K
2004-05-26CURAGEN CORPStock Option (Right to Buy)A Award+$13.4K

Recent filings

5

Companies

2

Address

3 MORE LONDON RIVERSIDE

LONDON, X0, SE1 2RE